Emre Sinan G€ ung€ or, MD , G€ ulşah _ Ilhan, MD, H€ useyin G€ ultekin, MD, Ali Galip Zebitay, MD, Serdar C€ omert, MD, Fatma Ferda Verit, MD Objectives-Respiratory distress syndrome (RDS) is a major cause of neonatal morbidity and mortality. It is primarily a disease of premature neonates. The aim of this study was to evaluate the impact of maternal betamethasone administration on the fetal pulmonary arteries (PAs) and umbilical arteries (UAs) and the correlation between RDS development and PA Doppler results.
N eonatal respiratory distress syndrome (RDS) refers to respiratory compromise presenting at or shortly after delivery and is related to a deficiency in pulmonary surfactant, a naturally occurring phospholipid that is required to decrease surface tension within the alveoli to prevent alveolar collapse. Respiratory distress syndrome remains a major cause of neonatal morbidity and mortality. 1 It is primarily a disease of premature neonates, with an incidence and severity that are highly dependent on gestational age (GA). 2, 3 As RDS is an important cause of neonatal morbidity and mortality, a number of biochemical tests have been developed to predict the risk of RDS. 4 Some of these tests, including amniocentesis, are invasive and are associated with risks to the pregnancy. A noninvasive test for predicting fetal lung maturity would be useful to minimize the need for invasive testing.
Antenatal steroid therapy is associated with improved neonatal outcomes, including a lower incidence of RDS in women at risk for preterm delivery. 5 The mechanism by which dexamethasone causes an improvement in respiratory and oxygen requirements is unclear.
Corticosteroids administered antenatally may increase production of surfactant in the fetal lungs, and an increase in the fetal pulmonary blood flow may be another possible explanation for such reduced morbidity. [3] [4] [5] [6] [7] Also, Doppler velocimetry of the umbilical artery (UA) was found to be affected by corticosteroid administration. 8 On the other hand, repeated doses of steroids may especially have adverse effects on fetal growth or neuronal myelination. 9, 10 Fetal pulmonary artery (PA) Doppler velocimetry may be useful for predicting fetal lung maturity. Fetal PA flow velocity waveforms have been measured throughout normal pregnancy and have been shown to change with advancing GA by some authors 6 but not by others. 11, 12 The aim of this study was to evaluate the impact of maternal betamethasone administration on fetal PAs and UAs and the correlation between RDS development and PA Doppler results.
Materials and Methods
We conducted a prospective study between February 2013 and December 2015. Singleton pregnancies between 24 and 34 gestational weeks with a diagnosis of preterm birth were included in the study. Patients in active labor or having contractions on a nonstress test were enrolled. We evaluated fetal PA and UA Doppler parameters in 40 women at risk for preterm birth who received corticosteroids (betamethasone) to accelerate fetal lung maturity. First, a PA and UA Doppler analysis was performed before steroid administration. All mothers in the study were given intramuscular betamethasone (12 mg) in 2 doses 24 hours apart, and 48 to 72 hours after the first dose, a second PA and UA Doppler analysis was performed. Written informed consent was obtained from all patients. Institutional Review Board approval was obtained. The procedures followed were in accord with the Declaration of Helsinki.
Gestational age (GA) was established by last menstrual period data and confirmed by first-trimester sonography. Exclusion criteria included multiple gestations, fetal growth below the 10th percentile or above the 90th percentile for GA, known chromosomal/structural abnormalities, preexisting maternal medical conditions (eg, diabetes and hypertensive disorders), vaginal bleeding, ruptured membranes, and active infection.
Maternal records were matched to neonatal charts, and demographic and outcome data were abstracted. Neonatal records providing information on neonatal sex, birth weight, Apgar scores, results of chest radiography if performed, and neonatal intensive care unit (NICU) admission were collected. Also, a blood sample from the UA was obtained and analyzed just after the birth of the neonate. Data for neonates who were admitted to the NICU with a diagnosis of RDS were collected. Neonatal RDS was diagnosed by the presence of at least 2 of the following 3 criteria: (1) evidence of respiratory compromise (tachypnea, retractions, or nasal flaring) shortly after delivery and a persistent oxygen requirement for longer than 24 hours; (2) administration of an exogeneous pulmonary surfactant; and (3) radiographic evidence of hyaline membrane disease.
We made Doppler recordings of the PAs with a Voluson 730 Pro ultrasound machine (GE Healthcare, Milwaukee, WI). All measurements were performed by the same examiner (H.G.), and measurements were done transabdominally. When a clear sonographic transverse cross section of the fetal chest was obtained at the level of the cardiac 4-chamber view, the color Doppler mode was switched on to visualize the pulmonary circulation. Both right and left main PAs were examined. Waveforms were obtained from the middle segment of the PA. A UA Doppler analysis was performed in a free segment of umbilical cord 5 to 6 cm from the placental or fetal insertion. The pulsatility index (PI) and resistive index (RI) were calculated automatically by the ultrasound equipment.
Data were expressed as mean 6 SD. A v 2 test was used for qualitative data. A logistic regression analysis was conducted to examine the relationship between the development of neonatal RDS and the fetal PA flow waveform parameters. Continuous variables were contrasted by the Mann-Whitney U test or Student t test. Data were analyzed with SPSS version 22.0 software (IBM Corporation, Armonk, NY). P < .05 was considered statistically significant.
Results
Maternal, perinatal, and neonatal characteristics of our study population are shown in Table 1 . There were no differences between groups for maternal age, body mass index, male-to-female ratio of neonates, mode of delivery, and mean GA at steroid administration. The incidences of cesarean deliveries were similar between the groups that developed RDS and did not. Apgar scores at 1 and 5 minutes were significantly lower for neonates who developed RDS. Also, birth weight and GA at birth were significantly lower for the neonates who developed RDS. Compared with the neonates who did not develop RDS, most of the neonates who developed RDS were admitted to the NICU. The median interval between admission and delivery and mean GA at delivery in the RDS-negative group were significantly higher than in the RDS-positive group.
The fetal PA evaluation was successfully completed in all cases. There were no statistically significant differences in PA Doppler results between fetuses who developed RDS and those who did not; moreover, we did not find significant differences in PA Doppler results before and after steroid administration for both groups (Table  2 ). Interestingly, for the patients who developed RDS, UA PI and RI results were significantly lower after steroid administration.
Discussion
Respiratory distress syndrome is a common reason for neonatal mortality and morbidity in preterm neonates. Administration of antenatal steroids to enhance fetal lung maturity is a well-known strategy that is used worldwide to avoid the development of RDS. Although it is believed that the administration of steroids improves fetal lung maturity, it is still not well known whether such a procedure changes the PA blood flow. The beneficial effects of antenatal steroid administration are greatest if greater than 24 hours and less than 7 days have elapsed between the initial administration of therapy and actual delivery. 13 Although it is accepted that steroid administration improves fetal lung maturation, different explanations for this positive effect have been proposed. One of the theories is a reduction in pulmonary vascular resistance and an increase in the pulmonary blood supply after steroid administration, but different opinions about such a theory have been reported. In addition, some studies of the possible effects of steroid administration have been reported. For example, Ishikawa et al 14 reported that administration of steroids was not effective in improving the short-or long-term outcome of smallfor-GA neonates. We evaluated the impact of steroid therapy on fetal PA and UA indices and whether there was a difference in the fetuses who developed RDS and those who did not. Similar to Lindsley et al, 15 we did not find a statistically significant difference in pulmonary blood flow between fetuses who developed RDS and those who did not. Also, Kim et al 5 reported that there were no significant differences in PA PI and RI scores between fetuses who developed RDS and those who did not. Different from us and the above-mentioned authors, Ustunyurt et al 16 reported significant decreases in the PA PI and RI at 24 and 48 hours after administration of the first dose of betamethasone (P 5 .02 and .01 for PI; P 5 .001 and .004 for RI, respectively). Similarly, Moety et al 17 also showed that, compared with fetuses who did not develop neonatal RDS, fetuses who developed RDS had a significantly higher PI and RI.
There are different reports about the effect of steroids used antenatally on the UA. Ekin et al 8 reported that, steroids were found to have no considerable effect on fetuses with normal UA blood flow. Our results for the UA PI and RI were similar to those of Thuring et al. 18 They reported a significant transient change in blood velocity waveforms and decreases in the PI in the UA and ductus venosus after maternal antenatal betamethasone treatment. This finding may indicate an effect of betamethasone on the fetoplacental circulation. Another possible explanation for the mechanism by which dexamethasone causes an immediate improvement in respiratory and oxygen requirements may be an effect mediated by suppression of inflammation. 19 Although we observed increased UA flow in neonates who developed RDS, it was unclear why it was limited to them. If it is accepted that these neonates are more immature than neonates who do not develop RDS, maybe such neonates have a more improved fetoplacental circulation after betamethasone injection.
The original hypothesis of this study was that the effect of dexamethasone might be mediated by a reduction in pulmonary vascular resistance. Since sonography is a noninvasive and a widely used technique in pregnancy, the PA Doppler results for the preterm neonates might provide additional data for distinguishing which neonates will develop RDS. The data we found did not support this hypothesis. Our study had some limitations. The sample size was small, and in some cases, the interval between steroid administration and birth was weeks, which makes an evaluation of the relationship between Doppler and clinical results for the neonate troublesome. Here, this question may be asked: Is steroid treatment performed unnecessarily in some patients who in fact actually will not really have premature birth? Such a treatment might increase unwanted side effects on the development of different organ systems: eg, neurodevelopmental effects of maternal glucocorticoid treatment are variable. 20, 21 Different from some other recent reports, we did not find any PA Doppler differences in fetuses with and without RDS. Also, there were no differences in PA Doppler results before and after steroid administration, but we observed a decreased UA PI in fetuses who developed RDS after steroid administration. Larger prospective studies are needed to accurately determine the impact of steroid administration on the fetal pulmonary and fetoplacental circulations.
